Wells Fargo tells investors to get very long utility stocks on AI power demand

Wells Fargo tells investors to get very long utility stocks on AI power demand

Investors ought to increase their exposure to utility stocks as companies build out energy-guzzling data centers to power an artificial intelligence boom, Wells Fargo advised clients. The bank initiated coverage of 33 companies across the utilities and power space, assigning a raft of stocks overweight ratings. “Power demand and tailwinds are structural, not cyclical, driving…

Read More
China buys three U.S. soybean cargoes ahead of Trump-Xi meeting, Reuters reports

China buys three U.S. soybean cargoes ahead of Trump-Xi meeting, Reuters reports

China’s state-owned COFCO bought three U.S. soybean cargoes this week, two trade sources said. Bloomberg | Bloomberg | Getty Images China’s state-owned COFCO bought three U.S. soybean cargoes this week, two trade sources said, the country’s first purchases from this year’s U.S. harvest ahead of this week’s summit of leaders Donald Trump and Xi Jinping. COFCO purchased about 180,000 metric tons of soybeans for December and January shipment through…

Read More
Bitcoin and ether fall as Federal Reserve’s October meeting kicks off: CNBC Crypto World

Bitcoin and ether fall as Federal Reserve’s October meeting kicks off: CNBC Crypto World

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email On today’s episode of CNBC Crypto World, BlackRock-linked Securitize, a “real world assets” platform, is going public through a merger with a special purpose acquisition company. Plus, Circle CEO Jeremy Allaire discusses the launch of a new blockchain network called Arc. And,…

Read More
Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments

Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments

Investors are noticing ripe opportunity in Cytokinetics, a late-stage biopharma company targeting medicines for specialty heart diseases, that has seen shares skyrocket in recent months. Shares of Cytokinetics have jumped about 69% over the past three months and are up 31% year to date. The stock is one of the top-performing San Francisco-based companies profiled…

Read More